pHAGE-PIK3CA-C420R Citations (1)

Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal

---

Articles Citing pHAGE-PIK3CA-C420R

Articles

Dyr726, a brain-penetrant inhibitor of PI3Kalpha, Type III receptor tyrosine kinases, and WNT signaling. Tandon V, Fistrovich A, Nogales J, Ferro F, Rokey SN, Cabel C, Miller AD, Yagel M, Duncan C, Atmasidha A, Sharma I, Wilms G, Williams K, Elliott R, Chavez T, Shaw Y, McMahon A, Ginn S, Basantes LE, Bedard N, Gokhale V, Ellis N, Prescott AR, Smith SJ, Rahman R, Becker W, Read KD, Chalmers AJ, Carragher N, Masson GR, Montfort W, Thorne C, Hulme C, Banerjee S. bioRxiv [Preprint]. 2025 Mar 29:2025.03.26.645490. doi: 10.1101/2025.03.26.645490. PubMed

If you have published an article using this material, please email us at to have your article added to this page.